Compact disc20 is an important target for the treatment of B-cell malignancies including non-Hodgkin lymphoma MK 3207 HCl as well as autoimmune disorders. for the development of GA101 as a promising new therapy for the treatment of B-cell disorders. Introduction Rituximab a type I chimeric IgG1 anti-CD20 antibody has revolutionized the management and treatment of… Continue reading Compact disc20 is an important target for the treatment of B-cell